Quarterly Transactions Made in Jounce Therapeutics, Inc. (JNCE)
This table provides information about the institutional ownership of Jounce Therapeutics, Inc. (JNCE). The information is specifically focused on institutions that hold shares of Jounce Therapeutics, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2020 | 164,723 | 2,581,806 | 2,746,529 | 1,752,576 | 511,240 | 2,263,816 | 482,713 | |
Q4 2020 | 3,387,688 | 2,780,567 | 6,168,255 | 2,288,997 | 640,583 | 2,929,580 | 3,238,675 | |
Q1 2021 | 1,736,929 | 11,014,626 | 12,751,555 | 3,980,722 | 1,456,307 | 5,437,029 | 7,314,526 | |
Q2 2021 | 3,567,740 | 5,980,786 | 9,548,526 | 4,342,046 | 1,814,816 | 6,156,862 | 3,391,664 | |
Q3 2021 | 2,480,525 | 4,627,871 | 7,108,396 | 4,037,284 | 1,951,636 | 5,988,920 | 1,119,476 | |
Q4 2021 | 4,353,296 | 7,849,274 | 12,202,570 | 3,698,537 | 3,091,560 | 6,790,097 | 5,412,473 | |
Q1 2022 | 6,185,138 | 783,739 | 6,968,877 | 3,425,859 | 2,452,972 | 5,878,831 | 1,090,046 | |
Q2 2022 | 5,359,549 | 656,455 | 6,016,004 | 1,935,530 | 2,892,138 | 4,827,668 | 1,188,336 | |
Q3 2022 | 2,639,044 | 1,888,609 | 4,527,653 | 3,472,067 | 62,646 | 3,534,713 | 992,940 | |
Q4 2022 | 5,166,928 | 3,489,028 | 8,655,956 | 7,350,283 | 0 | 7,350,283 | 1,305,673 | |
Q1 2023 | 3,081,539 | 16,542,609 | 19,624,148 | 8,571,725 | 0 | 8,571,725 | 11,052,423 | |
Q2 2023 | — | 2,210,056 | 1,559,587 | 3,769,643 | -3,769,643 | |||
Q3 2023 | — | 0 | 1,459,587 | 1,459,587 | -1,459,587 |